Terms: = Leukemia AND DDB2, Q92466, 1643, ENSG00000134574, FLJ34321 AND Clinical Outcome
4 results:
1. Validation of genes for H-ARS severity prediction in leukemia patients - interspecies comparison, challenges, and promises.
Schwanke D; Valente M; Ostheim P; Schüle S; Bobyk L; Drouet M; Riccobono D; Magné N; Daguenet E; Stewart SJ; Muhtadi R; Port M; Abend M
Int J Radiat Biol; 2024; 100(4):527-540. PubMed ID: 38227483
[TBL] [Abstract] [Full Text] [Related]
2. Impact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia.
Kayser S; Martínez-Cuadrón D; Rodriguez-Veiga R; Hänel M; Tormo M; Schäfer-Eckart K; Botella C; Stölzel F; Del Castillo TB; Keller U; Rodriguez-Medina C; Held G; Amigo ML; Schliemann C; Colorado M; Kaufmann M; Garcia MB; Krause SW; Görner M; Jost E; Steffen B; Zukunft S; Platzbecker U; Ho AD; Baldus CD; Serve H; Müller-Tidow C; Thiede C; Bornhäuser M; Montesinos P; Röllig C; Schlenk RF
Haematologica; 2023 Aug; 108(8):2059-2066. PubMed ID: 36815361
[TBL] [Abstract] [Full Text] [Related]
3. Longer Time Intervals From Symptom Onset to Diagnosis Affect the Overall Survival in Children With Acute Lymphoblastic leukemia.
Dai Q; Liu R; Wang Y; Ye L; Peng L; Shi R; Guo S; He J; Yang H; Zhang G; Jiang Y
J Pediatr Hematol Oncol; 2022 Aug; 44(6):285-292. PubMed ID: 34699460
[TBL] [Abstract] [Full Text] [Related]
4. Pediatric relapsed acute myeloid leukemia: a systematic review.
Hoffman AE; Schoonmade LJ; Kaspers GJ
Expert Rev Anticancer Ther; 2021 Jan; 21(1):45-52. PubMed ID: 33111585
[No Abstract] [Full Text] [Related]
